IVVD
Invivyd Inc.
NASDAQ: IVVD · HEALTHCARE · BIOTECHNOLOGY
$1.40
+2.94% today
Updated 2026-04-30
Market cap
$412.89M
P/E ratio
—
P/S ratio
7.73x
EPS (TTM)
$-0.30
Dividend yield
—
52W range
$0 – $3
Volume
2.8M
Invivyd Inc. (IVVD) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-98.30%
Operating margin
-73.00%
ROE
-34.00%
ROA
-17.10%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | — | $-111.98M | — | — | — |
| 2021 | $0.00 | $-226.79M | — | — | — |
| 2022 | $0.00 | $-241.32M | — | — | — |
| 2023 | $0.00 | $-198.64M | — | — | — |
| 2024 | $25.38M | $-169.93M | 93.63% | -696.80% | -669.42% |
| 2025 | $53.43M | $-52.49M | 92.99% | -103.99% | -98.25% |